Liraglutide and semaglutide improve cardiovascular and renal outcomes across most BMI categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Verma, S.; Bain, S. C.; Bhatt, D. L.; Leiter, L. A.; Mazer, C. D.; McGuire, D. K.; Pratley, R.; Zinman, B.; Lindberg, S.; Rasmussen, S.; Vrazic, H.; Buse, J. B.

authors

Publication Date

  • September 1, 2019

webpage

published in

category

start page

  • S560

end page

  • S560

volume

  • 62